British consumer goods group Reckitt Benckiser said it expected to post annual revenue growth at the top end of forecasts after a strong emerging markets performance and demand for its brands such as Dettol and Strepsils helped it to post first half sales up 6 percent.
To boost growth Reckitt is putting greater focus on its fastest growing health and hygiene brands like Dettol, Strepsils and Durex, and is moving quicker into the key emerging markets of Brazil, Russia, India and China.
The maker of Nurofen painkillers and Cillit Bang cleaners also on Monday said it remained bullish on demand for its heroin addiction drug Suboxone, despite competition from cheaper versions in tablet form.
First half sales rose 6 percent on a constant exchange rate to 5 billion pounds ($7.69 billion).
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
